Cystatin C Protein (Cst3) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about Cystatin C Protein, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
:: infobox infobox-protein
!Protein Name | Cystatin C (CST3)
!Gene | CST3
!UniProt ID | P01034
!PDB Structure | 1G96, 3GAX, 4JFL
!Molecular Weight | ~13 kDa (monomer)
!Subcellular Localization | Extracellular, secreted
!Protein Family | Cystatin family (type 2)
!
Cystatin C is a secreted cysteine protease inhibitor with a characteristic cystatin fold:
The protein forms a dimer at physiological concentrations, and dimerization is enhanced in the amyloidogenic L68Q variant.
Cystatin C has several important physiological functions:
Protease Inhibition: The primary function is inhibition of cathepsins B, H, L, and S, regulating extracellular matrix remodeling and protein turnover.
Antimicrobial Defense: Secreted cystatin C provides innate immunity against microbial invasion.
Cell Proliferation and Differentiation: CST3 modulates cell growth and differentiation through cathepsin inhibition.
Brain Function: In the CNS, cystatin C is produced by neurons and glia and regulates synaptic plasticity and memory formation.
The CST3 L68Q mutation (also called the "Icelandic mutation") causes autosomal dominant cerebral amyloid angiopathy:
Cystatin C has complex relationships with AD:
| Approach | Status | Description |
|---|---|---|
| Recombinant CST3 | Research | Neuroprotective protein therapeutic |
| CST3 Mimetics | Preclinical | Peptide analogs of protective region |
| Gene Therapy | Preclinical | AAV-mediated CST3 delivery |
Ghiso J, et al. (1986) "The cerebral amyloid angiopathy (CAA) in Iceland." Acta Med Scand 215:255-262.
Kaeser SA, et al. (2007) "Cystatin C modulates beta-amyloid aggregation." Neurobiol Aging 28:1023-1032. DOI:10.1016/j.neurobiolaging.2006.05.025
Skerget K, et al. (2020) "Cystatin C and its role in neurodegenerative diseases." Int J Mol Sci 21:8974. DOI:10.3390/ijms21238974
Benussi L, et al. (2021) "Cystatin C: A promising biomarker for Alzheimer's disease." J Prev Alzheimers Dis 8:324-333.
The study of Cystatin C Protein (Cst3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Reference 1
[2] Reference 2
[3] Reference 3